Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Headache- and migraine-inducing effects of apremilast in women with migraine without aura
2026-525987-16-00Phase 2Authorised
- Sponsor
- University of Southern Denmark
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine without aura comparing Apremilast STADA with Placebo (2 arms). Planned start Jul 2026; status: authorised.
02
Drugs
apremilast
03
Conditions
migraine without aura
Beyond the preview
Go deeper on 2026-525987-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525987-16-00.